NCR3 and chronic myelogenous leukemia, BCR-ABL1 positive: We have examined expression levels of all three natural cytotoxicity receptors NKp30, NKp44, and NKp46 and additional C-type lectin receptors NKG2A, NKG2C, NKG2D, CD161, and CD69 in Australian CML patients at time of TKI cessation and 3 and 6 months after (142).